|
|---|
| NYSGRC ID |
Priority |
stage |
Locus Tag |
NCBI GI |
Common Name |
Sequence
Length |
Project |
Homolog
PDB ID |
Homolog
Sequence
Identity |
Target Organism |
Request Person |
017850
(show subtarget assignments)
|
1 |
selected |
|
116490710 |
1,2-diacylglycerol 3-glucosyltransferase... |
431 |
BIO:GLY |
3C48
|
21.1% |
Oenococcus oeni |
|
|
|
017665
(show subtarget assignments)
|
1 |
selected |
|
91775143 |
1,2-diacylglycerol 3-glucosyltransferase... |
400 |
BIO:GLY |
2GEJ
|
24.2% |
Methylobacillus flagellatus |
|
|
|
017866
(show subtarget assignments)
|
1 |
cloned |
|
116492406 |
1,2-diacylglycerol 3-glucosyltransferase... |
391 |
BIO:GLY |
2JJM
|
24.5% |
Pediococcus pentosaceus |
|
|
|
009923
(show subtarget assignments)
|
1 |
selected |
BSU30980 |
2635582 |
1,4-alpha-glucan branching enzyme [Bacil... |
627 |
BIO:FDA (FDA-Approved Drug Targets) |
1M7X
|
42.1% |
Bacillus subtilis |
|
|
|
008771
(show subtarget assignments)
|
1 |
selected |
CPF_1840 |
110675941 |
1,4-alpha-glucan branching enzyme [Clost... |
659 |
BIO:FDA (FDA-Approved Drug Targets) |
3K1D
|
41.6% |
Clostridium perfringens |
|
|
|
007803
(show subtarget assignments)
|
1 |
selected |
LBA0680 |
58254319 |
1,4-alpha-glucan branching enzyme [Lacto... |
638 |
BIO:FDA (FDA-Approved Drug Targets) |
3K1D
|
40.3% |
Lactobacillus acidophilus |
|
|
|
008486
(show subtarget assignments)
|
1 |
selected |
SRU_0846 |
83756679 |
1,4-alpha-glucan branching enzyme [Salin... |
622 |
BIO:FDA (FDA-Approved Drug Targets) |
3K1D
|
49.1% |
Salinibacter ruber |
|
|
|
007542
(show subtarget assignments)
|
1 |
selected |
SP_1121 |
14972598 |
1,4-alpha-glucan branching enzyme [Strep... |
642 |
BIO:FDA (FDA-Approved Drug Targets) |
3K1D
|
38.8% |
Streptococcus pneumoniae |
|
|
|
008329
(show subtarget assignments)
|
1 |
selected |
Synpcc7942_1085 |
81168775 |
1,4-alpha-glucan branching enzyme [Synec... |
774 |
BIO:FDA (FDA-Approved Drug Targets) |
3K1D
|
46.7% |
Synechococcus elongatus |
|
|
|
009221
(show subtarget assignments)
|
1 |
selected |
|
1001448 |
1,4-alpha-glucan branching enzyme [Synec... |
770 |
BIO:FDA (FDA-Approved Drug Targets) |
3K1D
|
45.2% |
Synechocystis sp. |
|
|
|
012180
(show subtarget assignments)
|
1 |
cloned |
SMc04400 |
15076331 |
1,5-anhydro-D-fructose reductase [Sinorh... |
333 |
BIO:SINO (Sinorhizobium targets) |
2GLX
|
86.5% |
Sinorhizobium meliloti |
|
|
|
021259
(show subtarget assignments)
|
1 |
selected |
SMc02570 |
15963805 |
1-(5-phosphoribosyl)-5-[(5-phosphoribosy... |
247 |
BIO:SINO |
1VZW
|
34.8% |
Sinorhizobium meliloti |
|
|
|
021602
(show subtarget assignments)
|
1 |
selected |
SMc00826 |
15964524 |
16S ribosomal RNA methyltransferase RsmE... |
245 |
BIO:SINO |
1V6Z
|
32.7% |
Sinorhizobium meliloti |
|
|
|
015956
(show subtarget assignments)
|
1 |
selected |
PMN2A_1005 |
72382843 |
16S rRNA methyltransferase GidB [Prochlo... |
235 |
BIO:PRO |
1XDZ
|
31.5% |
Prochlorococcus marinus |
|
|
|
022893
(show subtarget assignments)
|
1 |
selected |
SMc02799 |
15967089 |
16S rRNA methyltransferase GidB [Sinorhi... |
213 |
BIO:SINO |
3G88
|
26.3% |
Sinorhizobium meliloti |
|
|
|
016130
(show subtarget assignments)
|
1 |
cloned |
P9303_26021 |
124024290 |
16S rRNA-processing protein RimM [Prochl... |
181 |
BIO:PRO |
2DYI
|
32.1% |
Prochlorococcus marinus |
|
|
|
004691
(show subtarget assignments)
|
1 |
selected |
TGGT1_064340 |
221480860 |
16S rRNA processing protein RimM, putati... |
388 |
BIO:SEC (Secreted Pathogen Proteins) |
|
|
Toxoplasma gondii |
|
|
|
022856
(show subtarget assignments)
|
1 |
selected |
SMc03860 |
15966996 |
16S rRNA-processing protein RimM [Sinorh... |
187 |
BIO:SINO |
2F1L
|
29.9% |
Sinorhizobium meliloti |
|
|
|
002521
(show subtarget assignments)
|
1 |
selected |
CbuG_0591 |
212010621 |
17 kDa common-antigen [Coxiella burnetii... |
150 |
BIO:SEC (Secreted Pathogen Proteins) |
|
|
Coxiella burnetii |
|
|
|
011040
(show subtarget assignments)
|
1 |
selected |
CBU_1425 |
29654717 |
17 kDa common-antigen [Coxiella burnetii... |
150 |
BIO:COX (Coxiella effectors) |
|
|
Coxiella burnetii |
|
|
|
003493
(show subtarget assignments)
|
1 |
selected |
PG1249 |
34540954 |
1-acyl-sn-glycerol-3-phosphate acetyltra... |
204 |
BIO:SEC (Secreted Pathogen Proteins) |
|
|
Porphyromonas gingivalis |
|
|
|
002562
(show subtarget assignments)
|
1 |
selected |
CbuG_0297 |
212010353 |
1-acyl-sn-glycerol-3-phosphate acyltrans... |
232 |
BIO:SEC (Secreted Pathogen Proteins) |
|
|
Coxiella burnetii |
|
|
|
003433
(show subtarget assignments)
|
1 |
selected |
MPN299 |
13508038 |
1-acyl-sn-glycerol-3-phosphate acyltrans... |
266 |
BIO:SEC (Secreted Pathogen Proteins) |
|
|
Mycoplasma pneumoniae |
|
|
|
018258
(show subtarget assignments)
|
1 |
selected |
|
154248588 |
1A family penicillin-binding protein |
804 |
BIO:GLY |
3UDF
|
31.5% |
Xanthobacter autotrophicus |
|
|
|
017058
(show subtarget assignments)
|
1 |
selected |
|
39998223 |
1A family penicillin-binding protein |
796 |
BIO:GLY |
3UDF
|
32.9% |
Geobacter sulfurreducens |
|
|
|
015486
(show subtarget assignments)
|
1 |
selected |
P9515_13061 |
123966539 |
1-deoxy-D-xylulose 5-phosphate reductois... |
409 |
BIO:PRO |
1K5H
|
43.6% |
Prochlorococcus marinus |
|
|
|
015524
(show subtarget assignments)
|
1 |
cloned |
NATL1_09721 |
124025679 |
1-deoxy-D-xylulose-5-phosphate synthase ... |
628 |
BIO:PRO |
2O1S
|
44.3% |
Prochlorococcus marinus |
|
|
|
016281
(show subtarget assignments)
|
1 |
selected |
OPAG_03895 |
356667022 |
1-hydroxy-2-glutathionyl-2-methyl-3-bute... |
222 |
BIO:N2F |
1YO6
|
30.1% |
Rhodococcus opacus |
|
|
|
004642
(show subtarget assignments)
|
1 |
selected |
TGGT1_111610 |
221488337 |
1-O-acylceramide synthase, putative [Tox... |
763 |
BIO:SEC (Secreted Pathogen Proteins) |
|
|
Toxoplasma gondii |
|
|
|
000296
(show subtarget assignments)
|
1 |
in_pdb
3QAN |
|
10175358 |
1-pyrroline-5-carboxylate dehydrogenase ... |
515 |
BIO:FDA (FDA-Approved Drug Targets) |
3QAN
|
100% |
Bacillus halodurans |
|
|
|
000299
(show subtarget assignments)
|
1 |
soluble |
|
10176565 |
1-pyrroline-5-carboxylate dehydrogenase ... |
515 |
BIO:FDA (FDA-Approved Drug Targets) |
3QAN
|
82.7% |
Bacillus halodurans |
|
|
|
000745
(show subtarget assignments)
|
1 |
cloned |
SRU_1517 |
83756236 |
1-pyrroline-5-carboxylate dehydrogenase ... |
562 |
BIO:FDA (FDA-Approved Drug Targets) |
3V9J
|
46.3% |
Salinibacter ruber |
|
|
|
000764
(show subtarget assignments)
|
1 |
cloned |
SSP0311 |
72494135 |
1-pyrroline-5-carboxylate dehydrogenase ... |
514 |
BIO:FDA (FDA-Approved Drug Targets) |
3QAN
|
60% |
Staphylococcus saprophyticus |
|
|
|
002299
(show subtarget assignments)
|
1 |
selected |
BURPS1710b_1258 |
76578385 |
200 kDa antigen p200, putative [Burkhold... |
526 |
BIO:SEC (Secreted Pathogen Proteins) |
|
|
Burkholderia pseudomallei |
|
|
|
010596
(show subtarget assignments)
|
1 |
selected |
SPO3440 |
56698263 |
20-beta-hydroxysteroid dehydrogenase, pu... |
250 |
BIO:FDA (FDA-Approved Drug Targets) |
1G6K
|
33.6% |
Ruegeria pomeroyi |
|
|
|
008517
(show subtarget assignments)
|
1 |
selected |
SRU_2282 |
83758167 |
20-beta-hydroxysteroid dehydrogenase [Sa... |
234 |
BIO:FDA (FDA-Approved Drug Targets) |
3UF0
|
35.5% |
Salinibacter ruber |
|
|
|
011587
(show subtarget assignments)
|
1 |
selected |
D44469.1 |
604904 |
20kDa virulence-associated antigen [Rhod... |
196 |
COV:NMR |
|
|
Rhodococcus equi |
|
|
|
007500
(show subtarget assignments)
|
1 |
selected |
PA4153 |
9950359 |
2,3-butanediol dehydrogenase [Pseudomona... |
363 |
BIO:FDA (FDA-Approved Drug Targets) |
1PL6
|
33.7% |
Pseudomonas aeruginosa |
|
|
|
008092
(show subtarget assignments)
|
1 |
selected |
PFL_2173 |
68343841 |
2,3-butanediol dehydrogenase, putative [... |
367 |
BIO:FDA (FDA-Approved Drug Targets) |
3QE3
|
32.2% |
Pseudomonas fluorescens |
|
|
|
008130
(show subtarget assignments)
|
1 |
selected |
PFL_3365 |
68345028 |
2,3-butanediol dehydrogenase, putative [... |
355 |
BIO:FDA (FDA-Approved Drug Targets) |
1E3J
|
33.5% |
Pseudomonas fluorescens |
|
|
|
000853
(show subtarget assignments)
|
1 |
selected |
BT_1236 |
29338543 |
2,3-cyclic-nucleotide 2-phosphodiesteras... |
580 |
BIO:SEC (Secreted Pathogen Proteins) |
2Z1A
|
20.8% |
Bacteroides thetaiotaomicron |
|
|
|
003757
(show subtarget assignments)
|
1 |
selected |
PPA1871 |
50843325 |
2',3'-cyclic-nucleotide 2'-phosphodieste... |
648 |
BIO:SEC (Secreted Pathogen Proteins) |
3QFK
|
22.2% |
Propionibacterium acnes |
|
|
|
009101
(show subtarget assignments)
|
1 |
selected |
A1S_2579 |
126388498 |
23-dihydro-2,3-dihydroxybenzoate dehydro... |
233 |
BIO:FDA (FDA-Approved Drug Targets) |
2FWM
|
44.6% |
Acinetobacter baumannii |
|
|
|
007721
(show subtarget assignments)
|
1 |
selected |
BL04020 |
52005400 |
2,3-dihydro-2,3-dihydroxybenzoate dehydr... |
256 |
BIO:FDA (FDA-Approved Drug Targets) |
2FWM
|
46.1% |
Bacillus licheniformis |
|
|
|
009929
(show subtarget assignments)
|
1 |
selected |
BSU32000 |
225185362 |
2,3-dihydro-2,3-dihydroxybenzoate dehydr... |
261 |
BIO:FDA (FDA-Approved Drug Targets) |
2FWM
|
41.8% |
Bacillus subtilis |
|
|
|
009316
(show subtarget assignments)
|
1 |
selected |
|
10173180 |
2,4-diaminobutyrate decarboxylase [Bacil... |
547 |
BIO:FDA (FDA-Approved Drug Targets) |
2OKK
|
20.1% |
Bacillus halodurans |
|
|
|
009898
(show subtarget assignments)
|
1 |
selected |
BSU14060 |
2633777 |
2,4-dienoyl-CoA reductase [Bacillus subt... |
254 |
BIO:FDA (FDA-Approved Drug Targets) |
3IMF
|
66.1% |
Bacillus subtilis |
|
|
|
010277
(show subtarget assignments)
|
1 |
selected |
|
16081355 |
2, 4-dienoyl-CoA reductase (NADPH) precu... |
282 |
BIO:FDA (FDA-Approved Drug Targets) |
1W6U
|
44.3% |
Thermoplasma acidophilum |
|
|
|
014526
(show subtarget assignments)
|
1 |
soluble |
RHE_PF00407 |
86361137 |
2,4-dienoyl-CoA reductase (NADPH) protei... |
678 |
BIO:N2F |
3K30
|
26.9% |
Rhizobium etli |
|
|
|
015744
(show subtarget assignments)
|
1 |
purified |
P9211_12881 |
159903829 |
2,4-dihydroxyhept-2-ene-1,7-dioic acid a... |
252 |
BIO:PRO |
2VWS
|
26.6% |
Prochlorococcus marinus |
|
|
|
015861
(show subtarget assignments)
|
1 |
soluble |
P9301_14021 |
126696740 |
2,4-dihydroxyhept-2-ene-1,7-dioic acid a... |
263 |
BIO:PRO |
1DXE
|
28.2% |
Prochlorococcus marinus |
|
|
|
014828
(show subtarget assignments)
|
1 |
selected |
RPC_3339 |
90106844 |
2,5-didehydrogluconate reductase [Rhodop... |
272 |
BIO:N2F |
3UP8
|
48.9% |
Rhodopseudomonas palustris |
|
|
|
014113
(show subtarget assignments)
|
1 |
purified |
Bpro_0086 |
91695224 |
2,5-dioxopentanoate dehydrogenase (NAD+)... |
505 |
BIO:N2F |
3IFG
|
40.2% |
Polaromonas sp. |
|
|
|
009870
(show subtarget assignments)
|
1 |
selected |
BSU02470 |
2632533 |
2,5-dioxovalerate dehydrogenase (alpha-k... |
488 |
BIO:FDA (FDA-Approved Drug Targets) |
1BI9
|
39.9% |
Bacillus subtilis |
|
|
|
022847
(show subtarget assignments)
|
1 |
selected |
SMc03835 |
15966971 |
2'-5' RNA ligase [Sinorhizobium meliloti... |
195 |
BIO:SINO |
1IUH
|
30.3% |
Sinorhizobium meliloti |
|
|
|
004639
(show subtarget assignments)
|
1 |
selected |
TGGT1_105160 |
221485210 |
26S proteasome AAA-ATPase subunit RPT1, ... |
626 |
BIO:SEC (Secreted Pathogen Proteins) |
3H4M
|
20.1% |
Toxoplasma gondii |
|
|
|
004212
(show subtarget assignments)
|
1 |
selected |
GL50803_91643 |
159117867 |
26S proteasome regulatory subunit, putat... |
1348 |
BIO:SEC (Secreted Pathogen Proteins) |
4ADY
|
8.9% |
Giardia lamblia |
|
|
|
004382
(show subtarget assignments)
|
1 |
selected |
TGGT1_083030 |
221486623 |
28 kDa antigen, putative [Toxoplasma gon... |
185 |
BIO:SEC (Secreted Pathogen Proteins) |
|
|
Toxoplasma gondii |
|
|
|
008929
(show subtarget assignments)
|
1 |
selected |
AAur_0142 |
119950116 |
2-amino-4-hydroxy-6-hydroxymethyldihydro... |
181 |
BIO:FDA (FDA-Approved Drug Targets) |
2QX0
|
35.3% |
Arthrobacter aurescens |
|
|
|
009306
(show subtarget assignments)
|
1 |
selected |
|
10172707 |
2-amino-4-hydroxy-6- hydroxymethyldihydr... |
174 |
BIO:FDA (FDA-Approved Drug Targets) |
3QBC
|
43.7% |
Bacillus halodurans |
|
|
|
000392
(show subtarget assignments)
|
1 |
soluble |
CJE0062 |
57165879 |
2-amino-4-hydroxy-6-hydroxymethyldihydro... |
157 |
BIO:FDA (FDA-Approved Drug Targets) |
2CG8
|
28% |
Campylobacter jejuni |
|
|
|
008285
(show subtarget assignments)
|
1 |
selected |
CPS_4341 |
71147063 |
2-amino-4-hydroxy-6-hydroxymethyldihydro... |
165 |
BIO:FDA (FDA-Approved Drug Targets) |
1CBK
|
28.5% |
Colwellia psychrerythraea |
|
|
|
015480
(show subtarget assignments)
|
1 |
selected |
P9211_03131 |
159902854 |
2-amino-4-hydroxy-6-hydroxymethyldihydro... |
193 |
BIO:PRO |
1CBK
|
27.4% |
Prochlorococcus marinus |
|
|
|
008189
(show subtarget assignments)
|
1 |
selected |
PFL_5657 |
68347244 |
2-amino-4-hydroxy-6-hydroxymethyldihydro... |
171 |
BIO:FDA (FDA-Approved Drug Targets) |
3QBC
|
31% |
Pseudomonas fluorescens |
|
|
|
008178
(show subtarget assignments)
|
1 |
selected |
PFL_5276 |
68346884 |
2-amino-4-hydroxy-6-hydroxymethyldihydro... |
159 |
BIO:FDA (FDA-Approved Drug Targets) |
2QX0
|
54.1% |
Pseudomonas fluorescens |
|
|
|
010586
(show subtarget assignments)
|
1 |
selected |
SPO3205 |
56698037 |
2-amino-4-hydroxy-6-hydroxymethyldihydro... |
188 |
BIO:FDA (FDA-Approved Drug Targets) |
2QX0
|
32.4% |
Ruegeria pomeroyi |
|
|
|
002089
(show subtarget assignments)
|
1 |
selected |
BMA10229_2212 |
124289255 |
2-aminoethylphosphonate ABC transporter,... |
360 |
BIO:SEC (Secreted Pathogen Proteins) |
2VOZ
|
23.4% |
Burkholderia mallei |
|
|
|
022547
(show subtarget assignments)
|
1 |
selected |
SMc00720 |
15966405 |
2-component receiver domain protein [Sin... |
119 |
BIO:SINO |
1S8N
|
36.1% |
Sinorhizobium meliloti |
|
|
|
022639
(show subtarget assignments)
|
1 |
selected |
SMc04044 |
15966580 |
2-component receiver domain protein [Sin... |
120 |
BIO:SINO |
2RDM
|
33.3% |
Sinorhizobium meliloti |
|
|
|
022476
(show subtarget assignments)
|
1 |
selected |
SMc01953 |
15966240 |
2-component receiver domain protein [Sin... |
128 |
BIO:SINO |
3N0R
|
27.3% |
Sinorhizobium meliloti |
|
|
|
022584
(show subtarget assignments)
|
1 |
selected |
SMc00653 |
15966472 |
2-component receiver domain protein [Sin... |
122 |
BIO:SINO |
3T6K
|
32% |
Sinorhizobium meliloti |
|
|
|
016242
(show subtarget assignments)
|
1 |
selected |
OPAG_05546 |
356662456 |
2-dehydro-3-deoxygalactonate kinase [Rho... |
336 |
BIO:N2F |
3R1X
|
30.6% |
Rhodococcus opacus |
|
|
|
014341
(show subtarget assignments)
|
1 |
cloned |
RHE_CH00854 |
86280602 |
2-dehydro-3-deoxygalactonokinase protein... |
305 |
BIO:N2F |
3T69
|
62.9% |
Rhizobium etli |
|
|
|
014423
(show subtarget assignments)
|
1 |
cloned |
RHE_CH03102 |
86282805 |
2-dehydro-3-deoxygluconokinase protein [... |
295 |
BIO:N2F |
4E69
|
49.2% |
Rhizobium etli |
|
|
|
005377
(show subtarget assignments)
|
1 |
selected |
PPA0985 |
50842469 |
2-dehydropantoate 2-reductase [Propionib... |
304 |
BIO:SEC (Secreted Pathogen Proteins) |
3GHY
|
32.6% |
Propionibacterium acnes |
|
|
|
009353
(show subtarget assignments)
|
1 |
selected |
|
10174786 |
2-deoxy-D-gluconate 3-dehydrogenase [Bac... |
250 |
BIO:FDA (FDA-Approved Drug Targets) |
3UF0
|
52.4% |
Bacillus halodurans |
|
|
|
008732
(show subtarget assignments)
|
1 |
selected |
CPF_0396 |
110673868 |
2-deoxy-D-gluconate 3-dehydrogenase [Clo... |
258 |
BIO:FDA (FDA-Approved Drug Targets) |
3CXR
|
44.9% |
Clostridium perfringens |
|
|
|
009205
(show subtarget assignments)
|
1 |
selected |
ECDH10B_3014 |
169890245 |
2-deoxy-D-gluconate 3-dehydrogenase [Esc... |
253 |
BIO:FDA (FDA-Approved Drug Targets) |
3UF0
|
44.7% |
Escherichia coli |
|
|
|
010128
(show subtarget assignments)
|
1 |
selected |
AF1207 |
11498806 |
2-deoxy-D-gluconate 3-dehydrogenase (kdu... |
281 |
BIO:FDA (FDA-Approved Drug Targets) |
1VL8
|
40.2% |
Archaeoglobus fulgidus |
|
|
|
010408
(show subtarget assignments)
|
1 |
selected |
ECA2401 |
50121329 |
2-deoxy-D-gluconate 3-dehydrogenase [Pec... |
253 |
BIO:FDA (FDA-Approved Drug Targets) |
3UF0
|
44.3% |
Pectobacterium atrosepticum |
|
|
|
012107
(show subtarget assignments)
|
1 |
in_crystallization_trials |
SMc02336 |
15075587 |
2-deoxy-D-gluconate 3-dehydrogenase [Sin... |
252 |
BIO:SINO (Sinorhizobium targets) |
3UF0
|
40.1% |
Sinorhizobium meliloti |
|
|
|
012489
(show subtarget assignments)
|
1 |
in_crystallization_trials |
SM_b21348 |
16264672 |
2-deoxy-D-gluconate 3-dehydrogenase [Sin... |
254 |
BIO:SINO (Sinorhizobium targets) |
3UF0
|
52% |
Sinorhizobium meliloti |
|
|
|
008046
(show subtarget assignments)
|
1 |
selected |
VF_A0997 |
59482428 |
2-deoxy-D-gluconate 3-dehydrogenase [Vib... |
251 |
BIO:FDA (FDA-Approved Drug Targets) |
3UF0
|
45.5% |
Vibrio fischeri |
|
|
|
009494
(show subtarget assignments)
|
1 |
selected |
|
28808215 |
2-deoxy-D-gluconate 3-dehydrogenase [Vib... |
253 |
BIO:FDA (FDA-Approved Drug Targets) |
3UF0
|
44.7% |
Vibrio parahaemolyticus |
|
|
|
023391
(show subtarget assignments)
|
1 |
selected |
SM_b21214 |
16264629 |
2-deoxyglucose-6-phosphate phosphatase [... |
240 |
BIO:SINO |
3S6J
|
28.8% |
Sinorhizobium meliloti |
|
|
|
008436
(show subtarget assignments)
|
1 |
selected |
Rru_A2981 |
83577225 |
2-desacetyl-2-hydroxyethyl bacteriochlor... |
317 |
BIO:FDA (FDA-Approved Drug Targets) |
|
|
Rhodospirillum rubrum |
|
|
|
015170
(show subtarget assignments)
|
1 |
selected |
Xaut_0646 |
154158683 |
(2Fe-2S)-binding domain protein [Xanthob... |
405 |
BIO:N2F |
1FFU
|
18.8% |
Xanthobacter autotrophicus |
|
|
|
014242
(show subtarget assignments)
|
1 |
cloned |
Bpro_3557 |
91698636 |
(2Fe-2S)-binding protein [Polaromonas sp... |
152 |
BIO:N2F |
1SIJ
|
38.2% |
Polaromonas sp. |
|
|
|
004620
(show subtarget assignments)
|
1 |
selected |
TGGT1_069760 |
221483374 |
2Fe-2S iron-sulfur cluster binding domai... |
317 |
BIO:SEC (Secreted Pathogen Proteins) |
3N9Z
|
13.5% |
Toxoplasma gondii |
|
|
|
014180
(show subtarget assignments)
|
1 |
in_pdb
4DLL |
Bpro_1712 |
91696819 |
2-hydroxy-3-oxopropionate reductase [Pol... |
298 |
BIO:N2F |
4DLL
|
100% |
Polaromonas sp. |
|
|
|
014126
(show subtarget assignments)
|
1 |
selected |
Bpro_0394 |
91695529 |
2-hydroxy-3-oxopropionate reductase [Pol... |
304 |
BIO:N2F |
4DLL
|
36.2% |
Polaromonas sp. |
|
|
|
014667
(show subtarget assignments)
|
1 |
in_crystallization_trials |
RSP_3442 |
77389862 |
2-hydroxyacid dehydrogenase [Rhodobacter... |
313 |
BIO:N2F |
3KBO
|
35.2% |
Rhodobacter sphaeroides |
|
|
|
016240
(show subtarget assignments)
|
1 |
selected |
OPAG_05584 |
356662419 |
2-hydroxycyclohexanecarboxyl-CoA dehydro... |
267 |
BIO:N2F |
3RKR
|
30.3% |
Rhodococcus opacus |
|
|
|
016270
(show subtarget assignments)
|
1 |
selected |
OPAG_07776 |
356665596 |
2-hydroxycyclohexanecarboxyl-CoA dehydro... |
264 |
BIO:N2F |
3RKR
|
31.8% |
Rhodococcus opacus |
|
|
|
016257
(show subtarget assignments)
|
1 |
selected |
OPAG_02222 |
356663785 |
2-hydroxycyclohexanecarboxyl-CoA dehydro... |
259 |
BIO:N2F |
1IY8
|
36.1% |
Rhodococcus opacus |
|
|
|
013714
(show subtarget assignments)
|
1 |
selected |
GYY_01790 |
339903803 |
2-hydroxyglutaryl-CoA dehydratase subuni... |
246 |
BIO:N2F |
1HUX
|
36.2% |
Methanococcus maripaludis |
|
|
|
013747
(show subtarget assignments)
|
1 |
selected |
GYY_03435 |
339904124 |
2-hydroxyglutaryl-CoA dehydratase subuni... |
411 |
BIO:N2F |
1HUX
|
20.4% |
Methanococcus maripaludis |
|
|
|
008658
(show subtarget assignments)
|
1 |
selected |
Rmet_1322 |
93354116 |
2-hydroxymuconic semialdehyde dehydrogen... |
503 |
BIO:FDA (FDA-Approved Drug Targets) |
2WME
|
39.3% |
Cupriavidus metallidurans |
|
|
|
018988
(show subtarget assignments)
|
1 |
selected |
|
195970150 |
2-isopropylmalate synthase |
569 |
BIO:SINO |
1SR9
|
52.1% |
Sinorhizobium meliloti |
|
|
|
015460
(show subtarget assignments)
|
1 |
cloned |
P9301_11721 |
126696510 |
2-isopropylmalate synthase [Prochlorococ... |
546 |
BIO:PRO |
3RMJ
|
39.6% |
Prochlorococcus marinus |
|
|
|
